Armata Pharmaceuticals Q3 EPS $(0.74) Misses $(0.42) Estimate, Sales $1.159M Miss $1.380M Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings MissesNews
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.42) by 76.19 percent. This is a 393.33 percent decrease over losses of $(0.15) per
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of $(0.42) by 76.19 percent. This is a 393.33 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $1.159 million which missed the analyst consensus estimate of $1.380 million by 16.01 percent. This is a 61.02 percent decrease over sales of $2.973 million the same period last year.